期刊文献+

一种新型抗菌强化磷酸钙骨水泥的研究

A new antibacterial and strength-reinforced calcium phosphate cements
原文传递
导出
摘要 目的探讨新型强化型抗菌磷酸钙骨水泥(CPC)的机械及抗菌性能。方法使用经过季铵盐基团改性的壳聚糖丝强化CPC骨水泥,通过涂板技术及激光共聚焦显微镜观察其抗菌效果;通过噻唑蓝(M盯)比色法及4’,6-二脒基-2-苯基吲哚(OAeI)染色观察其生物相容性;通过三点弯曲试验检测其力学性能。结果通过激光共聚焦可见新材料具有较好的抗菌效果,其细菌菌落比例为(0.10±0.09)%;三点弯曲试验表明经过壳聚糖丝改进后的机械性能[(17.3±4.5)MPa与(16.9±3.9)MPa]较之普通骨水泥有明显改善[(5.3±1.4)MPa];并且这样的改进对材料的生物相容性没有影响,其毒性试验显示新材料相容性比值为(97.5±3.3)%,细胞增殖实验3天吸光度值分别为0.237±0.025、0.503±0.015、0.726±0.03:2。结论新型的季铵盐壳聚糖强化型骨水泥无细胞毒性,具有良好的机械性能及抗菌效果。 Objective To evaluation the mechanical behavior and the ability of antibacterial of the new calcium phosphate bone cement ( CPC ). Methods The CPC was reinforced by chitosan fiber with hydroxypropyhrimethyl ammonium chloride chitosan (HACC). The spread plate analysis and confocal laser scanning microscopy were used for bacterial adherence assay. The strength of the samples was investigated by a standard three-point bending test. Cell toxicity and proliferation of cells were also invested. Results The new bone cement showed a good antibacterial activity which had the least amount of surviving bacterial as (0. 10 ± 0. 09 ) %. The results of three-point bending test also showed the incorporation of ehitosan fiber [ ( 17.3 ± 4. 5 ) MPa and ( 16.9 ± 3.9 ) MPa ] significantly increased the mechanical strength of CPC [ (5.3 ± 1.4) MPa ]. And the reinforcement has no harmful to the biocompatibility of CPC. Extracts of new bone cement showed non-cytotoxic (97.5 ±-3.3 )%. The methyl thiazol tetrazolium (MTT) activity of cells is 0. 237 ± 0. 025, 0. 503 _± 0. 015, 0. 726 ± 0. 032 during 3 days cultured. Conclusion CPC com- bined with chitosan fiber with HACC can meet the needs of strength, biocompatibility and antibacterial ac- tivity.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第4期808-811,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(81071487) 江苏省社会发展基金资助项目(BE2010744) 江苏省卫生厅资助项目(H201008)
关键词 磷酸钙骨水泥 抗菌 强化 壳聚糖 Calcium phosphate bone cement Antibacterial Reinforcement Chitosan
  • 相关文献

参考文献13

  • 1Sculco TP. The economic impact of infected joint arthroplasty. Ortho- pedics, 1995,18 : 871:873.
  • 2Kurtz S, Mowat F, Ong K, et al. Prevalence of primary and revision to- tal hip and knee arthroplasty in the United States from 1990 through2002. J Bone Joint Surg Am,2005,87:1487-1497.
  • 3Xu HH, Quinn JB. Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity. Biomaterials, 2002,23 : 193-202.
  • 4杨志明.我国组织工程实验研究的发展方向[J].中华实验外科杂志,2004,21(1):8-9. 被引量:25
  • 5肖飞,郑治,王剑龙.新型支架材料磷酸钙骨水泥-聚乳酸聚羟基乙酸二聚体复合物生物相容性的研究[J].中华实验外科杂志,2006,23(10):1254-1256. 被引量:9
  • 6lAu WC, Wong CT, Fong MK, et al. Gentamicin-loaded strontium-on- taining hydroxyapatite bioactive bone cement-an efficient bioactive an- tibiotic drug delivery system. Biomed Mater Res B, 2010,95 : 397- 406.
  • 7Shi Z, Neoh KG, Kang ET, et al. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacte- rial adhesion and enhancement of osteoblast functioris. Tissue Eng Part A ,2009,15:417-426.
  • 8Srivastav AK, Nadkarni B, Srivastav S, et al. Prophylactic use of anti- biotic-loaded bone cement in primary total knee arthroplasty:justified or not.9. Indian J Orthop,2009 ,43 :259-263.
  • 9Wu T, Hua X, He Z, et al. The bactericidal and biocompatible charac- teristics of reinforced calcium phosphate cements. Biomed Mater, 2012,7:045003.
  • 10Van de Belt H,Neut D,Schenk W,et al. Staphylococcus aureus bio- film formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials ,2001,22 : 1607-1611.

二级参考文献13

  • 1向其军,刘咏,郑治,苏哲安,王剑龙,肖飞.磷酸钙骨水泥/聚乳酸-聚羟基乙酸复合材料的制备及性能[J].粉末冶金材料科学与工程,2005,10(6):361-364. 被引量:5
  • 2杨柳.加强软骨与骨组织工程中关键技术的应用[J].中华实验外科杂志,2005,22(3):263-265. 被引量:25
  • 3Webb AR, Yang J, Ameer GA. Biodegradable polyester elastomers in tissue engineering. Expert Opin Biol Ther, 2004,4 : 801-812.
  • 4Majumdar MK, Banks V, Peluso DP, et al. Isolation, characterization,and chondrogenic poteintial of human bone marrow-derived multipotential stromal cells. J Cell Physiol, 2000,185 : 98-106.
  • 5Koort JK, Suokas E, Veiranto M, et al. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res A,2006,78:532-540.
  • 6Orhan Z, Cevher E, Mulazimoglu L, et al. The preparation of ciprofloxacin hydrochlorlde-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model. J Bone Joint Surg Br, 2006,88:270-275.
  • 7Wei G, Kotoura Y, Oka M, et al. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier. J Bone Jiont Surg Br,1991,73 :246-252.
  • 8Rodeheaver GT, Rukstalis D, Bono M, et al. A new model of bone infection used to evaluate the efficacy of antibiotic impregnated polymethylmethacrylate cement. Clin Orthop Relat Res, 1983,178:303-311.
  • 9Mader JT. Animal models of osteomyelitis. Am J Med, 1985,78:213-217.
  • 10Mader JT, Cripps MW, Calhoun JH. Adult posttraumatic osteomyelitis of the tibia. Clin Orthop Relat Res,1999,360:14-21.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部